Sex Differences in the Effectiveness of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors in Patients with Congestive Heart Failure — A Population Study

Abstract

These sex differences in treatment-related outcome are important but should be confirmed in a randomized trial before ARBs are preferentially prescribed to women with CHF.